Shandong Keyuan Pharmaceutical Co (SZSE:301281) Moat Score: 0/10 (As of Jul. 12, 2026)


SZSE:301281 Shandong Keyuan Pharmaceutical Co Ltd SZSE:301281
67 GF Score
Price ¥46.72
GF Value ¥30.41
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Shandong Keyuan Pharmaceutical Co Moat Score?

Shandong Keyuan Pharmaceutical Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Shandong Keyuan Pharmaceutical Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Shandong Keyuan Pharmaceutical Co might have No Moat - No discernible moat.

Shandong Keyuan Pharmaceutical Co  (SZSE:301281) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Shandong Keyuan Pharmaceutical Co Moat Score Related Terms

SZSE:301281
67GF Score
Shandong Keyuan Pharmaceutical Co Ltd SZSE:301281
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shandong Keyuan Pharmaceutical Co (SZSE:301281) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥46.72 is trading 53.6% above its estimated GF Value™ of ¥30.41. GuruFocus considers Shandong Keyuan Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SZSE:301281:

  • Moat Score: 0
  • GF Value™: ¥30.41 vs. price of ¥46.72 (53.6% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the SZSE:301281 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shandong Keyuan Pharmaceutical Co Business Description

Address Keyuan Street, Shandong Shanghe Economic Development Zone, Shandong Province, Jinan, CHN, 251601
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical raw materials and their preparations.
67GF Score

Get the complete analysis for SZSE:301281

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥46.72
Price
¥30.41
GF Value